Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;147(4):1145-1155.
doi: 10.1007/s00432-020-03397-2. Epub 2020 Sep 23.

Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals

Affiliations

Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals

Chengjing Zhou et al. J Cancer Res Clin Oncol. 2021 Apr.

Abstract

Purpose: Colorectal cancer (CRC) rarely occurs in children and adolescents. This study aimed to perform a retrospective analysis and disclose more detailed information about CRC in patients under 20 years old.

Methods: Medical records of CRCs in patients under 20 years old referred to three tertiary hospitals in China from September 2000 to July 2019 were retrospectively reviewed. Clinicopathological characteristics, treatment processes and laboratory findings were summarized and treatment outcomes and prognostic factors were analyzed.

Results: A total of 33,394 CRC medical records were analyzed, and we identified seventy (0.21%) CRCs in patients under 20. The most common primary tumor location was the left hemicolon (35.7%). The prominent pathological types were mucinous adenocarcinoma (22.9%) and signet ring cell carcinoma (22.9%). Nearly half (47.1%) of the patients presented with distant metastasis at diagnosis. The fractions of patients with deficient mismatch repair (dMMR) protein expression and microsatellite instability-high (MSI-H) were 23.8% (5/21) and 71.4% (5/7), respectively. Forty-four patients underwent radical surgery. Fifty-five patients received chemotherapy and six patients received radiotherapy. One dMMR/MSI-H rectal cancer patient received immunotherapy and achieved a clinically complete response. The median overall survival (OS) time was 80 months. The 3-year and 5-year OS rates were 61.8% and 57.2%, respectively. An absence of distant metastasis was a favorable factor for OS. For stage II/III CRCs, classic adenocarcinoma and radical surgery were favorable factors for OS. For stage IV CRCs, primary location at the colon was a favorable factor for OS.

Conclusion: Child and adolescent CRC patients are likely to have distant metastasis, undifferentiated, left hemicolon location, and a dMMR/MSI-H phenotype at diagnosis. Additional efforts are needed to improve their survival outcomes.

Keywords: Colorectal cancer; DNA mismatch repair; Pediatric cancer; Therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival curve of overall survival comparing stage II/III and IV (p = 0.001, log-rank test)
Fig. 2
Fig. 2
Kaplan–Meier survival curve of overall survival comparing classic adenocarcinoma vs. mucinous adenocarcinoma (MA) and signet ring cell carcinoma (SRCC) in stage II/III colorectal cancer patients (p = 0.019, log-rank test)
Fig. 3
Fig. 3
Kaplan–Meier survival curve of overall survival comparing rectum vs. colon in stage IV colorectal cancer patients (3a) (p = 0.044, log-rank test). Radical surgery vs. no radical surgery in stage IV colorectal cancer patients (3b) (p = 0.053, log-rank test)

Similar articles

Cited by

References

    1. Ahn CH, Kim SC. Two case reports: colorectal adenocarcinoma in children. Med (Balt) 2017;96(46):e8074. doi: 10.1097/MD.0000000000008074. - DOI - PMC - PubMed
    1. Andersson A, Bergdahl L. Carcinoma of the colon in children: a report of six new cases and a review of the literature. J Pediatr Surg. 1976;11(6):967–971. doi: 10.1016/s0022-3468(76)80075-9. - DOI - PubMed
    1. Arnold M, Sierra M, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi: 10.1136/gutjnl-2015-310912. - DOI - PubMed
    1. Auclin E, Zaanan A, Vernerey D, Douard R, Gallois C, Laurent-Puig P, et al. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy. Ann Oncol. 2017;28(5):958–968. doi: 10.1093/annonc/mdx030. - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed

MeSH terms

Substances